论文部分内容阅读
目的:对腹腔镜联合米非司酮治疗子宫内膜异位症的临床疗效进行观察研究。方法:抽取2011年1月-2012年12月祥云县人民医院接诊的132例子宫内膜异位症患者作为研究对象,按照随机数字表法将其分为观察组与对照组,每组各66例,对照组患者行腹腔镜手术治疗,观察组患者在对照组基础上联合使用米非司酮,观察并比较两组患者临床疗效。结果:观察组有效率为71.21%,总有效率为89.39%,复发率为9.10%,而对照组有效率为39.40%,总有效率为66.67%,复发率为36.36%,组间比较,差异具有统计学意义(P<0.05);观察组患者无副作用,而对照组副作用发生率为22.7%,组间比较,差异有统计学意义(P<0.05)。结论:腹腔镜联合米非司酮治疗子宫内膜异位症具有确切的疗效,安全性高,复发率低的优点。
Objective: To observe the clinical efficacy of laparoscopy combined with mifepristone in the treatment of endometriosis. Methods: Thirty-two patients with endometriosis who were admitted to Xiangyun People’s Hospital from January 2011 to December 2012 were selected as study subjects and divided into observation group and control group according to random number table Sixty-six patients in the control group underwent laparoscopic surgery. The patients in the observation group were treated with mifepristone on the basis of the control group, and the clinical efficacy was observed and compared between the two groups. Results: The effective rate of the observation group was 71.21%, the total effective rate was 89.39%, the recurrence rate was 9.10%, while the effective rate of the control group was 39.40%, the total effective rate was 66.67%, the recurrence rate was 36.36% (P <0.05). There was no side effect in the observation group while the incidence of side effects in the control group was 22.7%. There was significant difference between the two groups (P <0.05). Conclusion: Laparoscopy combined with mifepristone in the treatment of endometriosis has the exact effect, high safety and low recurrence rate.